30
CARDIOVASCULAR
hamburger

The Right Fit

A lasting fit for your patients, a reliable fit for you

The Right Fit

A lasting fit for you patients, a reliable fit for you
A Lasting Fit For Your Patients
  • Lasting Comfort
  • Lasting Care
  • Lasting Performance
 
A Reliable Fit For You
  • Reliable Implant Experience
  • Reliable Leadership
  • Reliable Technology
The Right Fit - A lasting fit for your patients

The Right Fit
A Lasting Fit For Your Patients

 
 
Tendril™ portfolio of pacing leads implanted worldwide

More than 2.1 million

 
Assurity™ and Endurity™ portfolio of pacemakers implanted worldwide

More than 1 million

BECAUSE PATIENT NEEDS EVOLVE, SO DO OUR PRODUCTS

Lasting Care

Remote monitoring options allow you to manage your patient’s changing needs with less risk or compromise. Enables early detection of AT/AF to reduce patient risk of stroke.

graphic showing 2.5x increased stroke risk

2.5x increased stroke risk for pacemaker patients with device detected asymptomatic atrial tachyarrhythmias (AT/AF)(p=0.007)1

Clock graphic

AT/AF episodes as short as 6 minutes in duration increase the risk of stroke1

Calendar graphic

35 day median time to first detection of asymptomatic AT/AF by pacemaker1

 
Reduction in hospitalizations for AF or stroke for pacemaker patients using remote monitoring2

circle chart showing 66%

 
 
of pacemaker patients have asymptomatic AT/AF1

circle chart showing 35%

Lasting Comfort

Smaller device and physiologic shape reduces the pocket size to lower the risk for complications and increase patient comfort.³

Lasting Performance

Abbott is committed to reducing your patient’s risk over the long-term.

calendar graphic showing 10 years

10+ years device longevity backed by unequaled 10-year global warranty

hospital graphic

Reduces your patient’s need for high-risk device replacement procedures

graphic of an arrow with a dollar sign pointing down

Lowering the risk for complications over a lifetime can mean less costs for patients and clinics4-7

References

*Among pacemakers < 15 cc in total volume. As of September 2017. St. Jude Medical Research Report: Competitive Product Review: Wireless Pacemakers. 2016. No. 60082151.
†Longevity parameters: 2.5V, 600 Ohm, EGM On, 100% pacing.

  1. Healey. et al. Subclinical Atrial Fibrillation and the Risk of Stroke. N Engl J Med 2012; 366:120-9
  2. Mabo, P. et al. A Randomized Trial of Long-term Remote Monitoring of Pacemaker Recipient (The COMPAS trial). European Heart Journal. doi:10.1093/eurheartj/ehr419
  3. Romey er-Bouchard C., DaCosta A., DauphinotV., Messier M., BischL., Samuel B., Lafond, P., ... IsaazK. (2010).Prevalence and risk factors related to infections of cardiac resy nchronization therapy devices. European Heart Journal, 31(2), 203-210.
  4. Sohail, M. R., Uslan, D. Z., Khan, A. H., Friedman, P. A., Hayes, D. L., Wilson, W. R., ... Baddour, L. M. (2007). Risk factor analysis of permanent Pacemaker infection. Clinical Infectious Diseases, 45(2), 166-173.
  5. Poole, J., Gleva, M., Mela, T., Chung, M. K., Uslan, D. Z., Borge, R., ... Holcomb, R. (2010). Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation, 122, 1553-1561.
  6. Sohail, M. R., Henrikson, A., Braid-Forbes, M. J., Forbes, K. F., & Lerner, D. J. (2011). Mortality and cost associated with cardiovascular implantable electronic device infections. Archives of Internal Medicine, 171, 1821-1828.
  7. Le, K. Y., Sohail, M. R., Friedman, P. A., Uslan, D. Z., Cha, S. S., Hayes, D. L., ... Baddour, L, M. (2011). Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm, 8,1678-1685.

MAT-2005930 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

True
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.